These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16924649)

  • 1. Role of intra-arterial steroid administration in the management of steroid-refractory acute gastrointestinal graft-versus-host disease.
    Tfayli A; Selby G; Maqbool F; Bierbaum W; Hamadani M
    Am J Hematol; 2006 Dec; 81(12):959-62. PubMed ID: 16924649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-arterial methylprednisolone for severe steroid refractory gastrointestinal graft-versus-host disease.
    Bhuller KS; Heran MK; Wu JK; Rassekh SR
    Pediatr Blood Cancer; 2014 Dec; 61(12):2321-3. PubMed ID: 25053422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal hyperacute graft-versus-host disease following denileukin diftitox treatment for recurrent t cell lymphoma after allogeneic stem cell transplantation.
    Khubchandani S; Deeb G; Smiley SL; Battiwalla M; Paplham P; Brown K; Syta M; Hahn T; Cheney R; McCarthy PL; Hong F
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):887-90. PubMed ID: 19539223
    [No Abstract]   [Full Text] [Related]  

  • 4. Intra-arterial catheter guided steroid administration for the treatment of steroid-refractory intestinal GvHD.
    Bürgler D; Medinger M; Passweg J; Fischmann A; Bucher C
    Leuk Res; 2014 Feb; 38(2):184-7. PubMed ID: 24268317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease.
    Milner LA; Becker MW; Bernstein SH; Bruckner L; Friedberg JW; Holland GA; Ifthikharuddin JJ; Liesveld JL; Mathes EJ; Menchel HL; Mullen CA; Sasson T; Phillips GL
    Am J Hematol; 2011 Aug; 86(8):712-4. PubMed ID: 21630317
    [No Abstract]   [Full Text] [Related]  

  • 6. Intra-arterial methylprednisolone infusion in treatment-resistant graft-versus-host disease.
    Weintraub JL; Belanger AR; Sung CC; Stangl PA; Nowakowski FS; Lookstein RL
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):509-12. PubMed ID: 20063098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute gastrointestinal graft-versus-host disease in pediatric patients: serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival.
    Goussetis E; Paisiou A; Kitra V; Peristeri I; Vessalas G; Stefanaki K; Panayotou I; Giamaiou K; Kontou E; Kitzoni M; Dimopoulou MN; Karkelis S; Kafritsa Y; Rapsomaniki E; Papassotiriou I; Tsirigotis P; Roma E; Graphakos S
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1058-66. PubMed ID: 21073975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
    Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
    Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment with steroids of upper gastrointestinal acute graft vs. host disease after hematopoietic stem cell transplantation.
    Nishi T; Okazaki K; Fujii S; Uchida K; Uose S; Nakase H; Ohana M; Nishihara T; Chiba T
    Endoscopy; 2001 Nov; 33(11):985-7. PubMed ID: 11668409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited benefit of pentostatin salvage therapy for steroid-refractory grade III-IV acute graft-versus-host disease.
    Alam N; Atenafu EG; Tse G; Viswabandya A; Gupta V; Kim D; Lipton JH; Messner HA; Kuruvilla J
    Clin Transplant; 2013; 27(6):930-7. PubMed ID: 24304375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Ho VT; Zahrieh D; Hochberg E; Micale E; Levin J; Reynolds C; Steckel S; Cutler C; Fisher DC; Lee SJ; Alyea EP; Ritz J; Soiffer RJ; Antin JH
    Blood; 2004 Aug; 104(4):1224-6. PubMed ID: 15113758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of severe acute gastrointestinal graft-versus-host disease complicated by cytomegalovirus gastroenteritis with intra-arterial steroid infusion.
    Hirabayashi S; Kondo T; Oka T; Akamatsu Y; Hishizawa M; Shibata T; Kitano T; Takaori-Kondo A
    Ann Hematol; 2016 Aug; 95(8):1373-5. PubMed ID: 27138923
    [No Abstract]   [Full Text] [Related]  

  • 13. Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease.
    Shaughnessy PJ; Bachier C; Grimley M; Freytes CO; Callander NS; Essell JH; Flomenberg N; Selby G; Lemaistre CF
    Biol Blood Marrow Transplant; 2005 Mar; 11(3):188-93. PubMed ID: 15744237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial steroid-injection therapy for steroid-refractory acute graft-versus-host disease with the evaluation of angiography.
    Nakai K; Tajima K; Tanigawa N; Matsumoto N; Zen K; Nomura S; Fujimoto M; Kishimoto Y; Amakawa R; Sawada S; Fukuhara S
    Bone Marrow Transplant; 2004 Jun; 33(12):1231-3. PubMed ID: 15094752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial catheter directed therapy for severe graft-versus-host disease.
    Shapira MY; Bloom AI; Or R; Sasson T; Nagler A; Resnick IB; Aker M; Zilberman I; Slavin S; Verstanding A
    Br J Haematol; 2002 Dec; 119(3):760-4. PubMed ID: 12437655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody.
    Kobbe G; Schneider P; Rohr U; Fenk R; Neumann F; Aivado M; Dietze L; Kronenwett R; Hünerlitürkoglu A; Haas R
    Bone Marrow Transplant; 2001 Jul; 28(1):47-9. PubMed ID: 11498743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute graft-versus-host disease of the lung after liver transplantation.
    Knox KS; Behnia M; Smith LR; Vance GH; Busk M; Cummings OW; Kwo PY; Wilkes DS
    Liver Transpl; 2002 Oct; 8(10):968-71. PubMed ID: 12360443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment options in steroid-refractory acute graft-versus-host disease following hematopoietic stem cell transplantation.
    Kim SS
    Ann Pharmacother; 2007 Sep; 41(9):1436-44. PubMed ID: 17684033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II clinical studies of denileukin diftitox diphtheria toxin fusion protein in patients with previously treated chronic lymphocytic leukemia.
    Frankel AE; Surendranathan A; Black JH; White A; Ganjoo K; Cripe LD
    Cancer; 2006 May; 106(10):2158-64. PubMed ID: 16586495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denileukin diftitox as prophylaxis against graft-versus-host disease in the canine hematopoietic cell transplantation model.
    Mielcarek M; Georges GE; Storb R
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):899-904. PubMed ID: 16920555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.